Efavirenz Completed Phase 2 Trials for Lipodystrophies / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00021463Changing to Nonprotease Inhibitor Treatment to Improve Side Effects